IMOCOLIBOV
IMOCOLIBOV
Authorised
- Escherichia coli, serotype O78, Inactivated
- Escherichia coli, serotypes O9 and O101 (fimbrial adhesin F5), Inactivated
- Escherichia coli, serotypes O117 and O8 (antigen Y), Inactivated
- Escherichia coli, serotypes O15 and O8 (antigen 31A), Inactivated
Product identification
Medicine name:
IMOCOLIBOV
Active substance:
- Escherichia coli, serotype O78, Inactivated
- Escherichia coli, serotypes O9 and O101 (fimbrial adhesin F5), Inactivated
- Escherichia coli, serotypes O117 and O8 (antigen Y), Inactivated
- Escherichia coli, serotypes O15 and O8 (antigen 31A), Inactivated
Target species:
-
Cattle
-
Sheep
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Escherichia coli, serotype O78, Inactivated1.14/unit(s)1.00millilitre(s)
-
Escherichia coli, serotypes O9 and O101 (fimbrial adhesin F5), Inactivated0.90/titre1.00millilitre(s)
-
Escherichia coli, serotypes O117 and O8 (antigen Y), Inactivated0.90/titre1.00millilitre(s)
-
Escherichia coli, serotypes O15 and O8 (antigen 31A), Inactivated0.90/titre1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Cattle
-
All relevant tissues0day
-
-
Sheep
-
All relevant tissues0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI02AB06
- QI04AB04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/4655745 4/1981
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?: